Research Article
Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer
Table 1
The prognostic value of the mRNA expression of ERCC in different clinical stage GC patients.
| Genes | Stage | cases | HR (95% CI) | P-value |
| ERCC1 | I | 39 | 0.31 (0.1–0.94) | 0.029 | | II | 49 | 1.54 (0.62–3.78) | 0.35 | | III | 217 | 0.83 (0.6–1.15) | 0.26 | | IV | 77 | 2.64 (1.48–4.71) | 0.00068 | ERCC2 | I | 39 | 3.17 (0.96–10.44) | 0.046 | | II | 49 | 0.57 (0.21–1.55) | 0.26 | | III | 217 | 1.35 (0.95–1.91) | 0.096 | | IV | 74 | 1.89 (1.06–3.36) | 0.028 | ERCC3 | I | 39 | 2.68 (0.73–9.87) | 0.12 | | II | 49 | 0.46 (0.19–1.07) | 0.065 | | III | 217 | 1.25 (0.9–1.75) | 0.19 | | IV | 74 | 0.75 (0.43–1.32) | 0.32 | ERCC4 | I | 39 | 5.03 (1.11–22.74) | 0.02 | | II | 49 | 3.29 (139.–7.77) | 0.0043 | | III | 217 | 1.45 (0.98–2.13) | 0.063 | | IV | 74 | 0.72 (0.41–1.27) | 0.25 | ERCC5 | I | 39 | 0.29 (0.06–1.32) | 0.088 | | II | 49 | 0.36 (0.13–0.99) | 0.038 | | III | 217 | 1.27 (0.87–1.85) | 0.22 | | IV | 74 | 0.57 (0.31–1.04) | 0.065 | ERCC6 | I | 39 | 7.09 (0.91–55.24) | 0.03 | | II | 49 | 2.84 (1.22–6.62) | 0.012 | | III | 217 | 1.23 (0.86–1.76) | 0.26 | | IV | 74 | 0.62 (0.35–1.09) | 0.095 | ERCC8 | I | 34 | 0.23 (0.06–0.83) | 0.015 | | II | 44 | 1.68 (0.65–4.34) | 0.28 | | III | 109 | 1.46 (0.91–2.36) | 0.12 | | IV | 66 | 0.66 (0.37–1.2) | 0.17 |
|
|
Notes. ERCC, excision repair cross-complementing; GC, gastric cancer; HR, hazard ratio; CI, confidence interval.
|